GlassScriptPhysician profile
Sekar Annamalai
NPI 1851345334
$4,803.28
in general payments reported to CMS, 2019-2025
48 companies · $586 in 2025
The $586 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $899 · 2020: $473 · 2021: $643 · 2022: $771 · 2023: $814 · 2024: $617 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,017.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,211.89 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $383.09 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $329.85 | 2019-2025 | Spiriva Respimat, Stiolto Respimat |
| United Therapeutics Corporation | $292.53 | 2019-2023 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $234.66 | 2021-2023 | Opsumit, Uptravi |
| Amgen INC. | $197.00 | 2019-2024 | Repatha |
| Abbott Laboratories | $166.10 | 2022-2025 | Octrode, Eterna, Assurity |
| Electromed, INC. | $115.79 | 2019-2023 | Smartvest |
| Mylan Specialty L.P. | $106.67 | 2020-2023 | Yupelri |
| Pfizer INC. | $104.82 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $104.17 | 2020-2023 | Glassia |
| Lilly USA, LLC | $101.31 | 2025 | Mounjaro, Zepbound, Kisunla |
| Astellas Pharma US INC | $98.44 | 2019-2024 | Veozah |
| Philips North America LLC | $90.40 | 2022-2023 | |
| Novo Nordisk INC | $90.21 | 2024-2025 | Ozempic, Rybelsus |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $80.00 | 2025 | |
| Janssen Pharmaceuticals, INC | $74.04 | 2019-2021 | |
| Abbvie INC. | $72.50 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $68.28 | 2022-2024 | |
| Amarin Pharma, INC. | $65.68 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $64.49 | 2019-2024 | Eliquis |
| Boston Scientific Corporation | $51.05 | 2020-2023 | Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $45.54 | 2024 | Resolute Onyx, Minimed 780g |
| Grifols USA, LLC | $41.55 | 2019-2020 | |
| Exact Sciences Corporation | $36.92 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Gilead Sciences, INC. | $34.82 | 2019-2022 | |
| Pulmonx Corporation | $33.71 | 2021-2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Shire North American Group INC | $33.55 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $32.59 | 2023-2025 | Zoryve, Seglentis |
| Regeneron Healthcare Solutions, INC. | $31.82 | 2019-2022 | |
| Angiodynamics, INC. | $30.76 | 2025 | Auryon Laser System 100-120 Vac |
| Edwards Lifesciences Corporation | $30.76 | 2024 | Sapien 3 Ultra Resilia |
| Teleflex LLC | $30.33 | 2022 | |
| Eisai INC. | $29.96 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.60 | 2024 | Xifaxan, Trulance |
| Paratek Pharmaceuticals, INC. | $29.21 | 2020-2021 | |
| Radius Health, INC. | $28.15 | 2020 | |
| Aimmune Therapeutics, INC. | $27.39 | 2025 | Zenpep |
| Merck Sharp & Dohme LLC | $26.99 | 2024 | Dificid |
| Corcept Therapeutics | $24.79 | 2025 | Korlym |
| Nestle Healthcare Nutrition INC. | $21.40 | 2021 | |
| Inspire Medical Systems, INC. | $16.66 | 2025 | Inspire |
| Strongbridge US INC. | $16.63 | 2020 | |
| Xeris Pharmaceuticals, INC. | $15.35 | 2022 | |
| Lucid Diagnostics INC. | $13.90 | 2022 | |
| Seqirus USA INC | $13.76 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Baxter Healthcare | $12.73 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Breas Medical, INC. | $11.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sekar Annamalai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.